Relapse mortality and treatment-related mortality
| . | CMVseronegative (n = 35) . | CMVseropositive (n = 80) . |
|---|---|---|
| Relapse | 5 | 17 |
| Treatment-related mortality | 6 | 30 |
| Specific causes | ||
| CMV disease | — | 2 |
| GVHD | 1 | 3 |
| Interstitial pneumonitis | 3 | 9 |
| Pneumonia | ||
| Aspergillus fumigatus | — | 1 |
| Streptococcus pneumoniae | — | 1 |
| Pneumocystis carinii | — | 2 |
| ECI | — | 2 |
| ARDS/sepsis | — | 6 |
| VOD/HUS | — | 3 |
| EBV-LPD | 1 | — |
| Hemorrhage | 1 | 1 |
| . | CMVseronegative (n = 35) . | CMVseropositive (n = 80) . |
|---|---|---|
| Relapse | 5 | 17 |
| Treatment-related mortality | 6 | 30 |
| Specific causes | ||
| CMV disease | — | 2 |
| GVHD | 1 | 3 |
| Interstitial pneumonitis | 3 | 9 |
| Pneumonia | ||
| Aspergillus fumigatus | — | 1 |
| Streptococcus pneumoniae | — | 1 |
| Pneumocystis carinii | — | 2 |
| ECI | — | 2 |
| ARDS/sepsis | — | 6 |
| VOD/HUS | — | 3 |
| EBV-LPD | 1 | — |
| Hemorrhage | 1 | 1 |
CMV indicates cytomegalovirus; GVHD, graft-versus-host disease; ECI, e causa ignota; ARDS, adult respiratory distress syndrome; VOD, veno-occlusive disease; HUS, hemolytic uremic syndrome; EBV-LPD, Epstein-Barr virus–lymphoproliferative disease.